Phoenix rocker shares the story behind "Jason P. Woodbury & The Night Bird Singing Quartet," from childhood memories of ...

More than half contained illegal amounts of THC. Some had mold and pesticides. And one contained a highly toxic chemical.

After years of backing the legalization of marijuana in the U.S., The New York Times changed course in an editorial published Tuesday. In the piece, entitled "It’s Time for America to Admit That It ...

For nearly five decades, Steven Spielberg has helped define what alien stories mean to movie audiences. Sometimes they arrive as cosmic miracles. Sometimes as existential threats. Sometimes as ...

A new Ohio law, Senate Bill 56, bans THC drinks and most hemp-derived cannabis products. Advocates are trying to repeal the law through a referendum, which requires nearly 250,000 signatures. The ...

ADHD is common and is progressively being recognized as a disorder affecting people across the lifespan. ADHD is associated with multiple negative personal outcomes, including lower education, ...

In December 2025, the Trump administration accelerated the process of reclassifying marijuana from Schedule I to Schedule III under the Controlled Substances Act – a shift that would reduce ...

Pass the pot to Grandma — her brain might thank you. A new study is challenging long-held assumptions about cannabis, finding that middle-aged and older adults who use the drug may actually see some ...

Will Florida voters get the chance to make recreational marijuana legal this November? That depends who you ask. State Attorney General James Uthmeier said no this week, citing a lack of valid ...

Forbes contributors publish independent expert analyses and insights. A.J. Herrington is a freelance writer covering weed news and culture. Democratic lawmakers in Wisconsin on Monday unveiled new ...

In today’s complex financial environment, governments need to juggle any number of security threats while keeping the global markets functioning smoothly. From AI attacks to widespread civil war, ...

Cannabis-based medicines have been widely promoted as a potential answer for people living with chronic nerve pain—but a major new review finds the evidence just isn’t there yet. After analyzing more ...